Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Employment agrmnt
Quarterly results
Appointed director
|
|
Fortress Biotech, Inc. (FBIO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/05/2013 |
8-K
| Amended existing or entered into new employment agreement with an officer, Quarterly results|
Docs:
|
"Amendment to Employment Agreement by and between Coronado Biosciences, Inc. and Dr. Karin Hehenberger, M.D., Ph.D",
"CORONADO BIOSCIENCES REPORTS FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2013 Burlington, MA - August 5, 2013 - Coronado Biosciences, Inc. , a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer, announced today its financial results for the second quarter ended June 30, 2013." |
|
| 12/22/2011 |
8-K
| Form 8-K - Current report |
|
|